401 related articles for article (PubMed ID: 30838705)
1. Dachengqi decoction alleviates acute lung injury and inhibits inflammatory cytokines production through TLR4/NF-κB signaling pathway in vivo and in vitro.
Hu X; Liu S; Zhu J; Ni H
J Cell Biochem; 2019 Jun; 120(6):8956-8964. PubMed ID: 30838705
[TBL] [Abstract][Full Text] [Related]
2. Dachengqi Decoction Attenuates Intestinal Vascular Endothelial Injury in Severe Acute Pancreatitis in Vitro and in Vivo.
Pan LY; Chen YF; Li HC; Bi LM; Sun WJ; Sun GF; Zhang XF; Xu K; Feng DX
Cell Physiol Biochem; 2017; 44(6):2395-2406. PubMed ID: 29262394
[TBL] [Abstract][Full Text] [Related]
3. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
4. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
7. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
8. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
9. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
[TBL] [Abstract][Full Text] [Related]
10. Ugonin M, a Helminthostachys zeylanica Constituent, Prevents LPS-Induced Acute Lung Injury through TLR4-Mediated MAPK and NF-κB Signaling Pathways.
Wu KC; Huang SS; Kuo YH; Ho YL; Yang CS; Chang YS; Huang GJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28368327
[No Abstract] [Full Text] [Related]
11. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
Li R; Yang H; Xue Y; Xianqin L
J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
[TBL] [Abstract][Full Text] [Related]
12. Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway.
Deng G; He H; Chen Z; OuYang L; Xiao X; Ge J; Xiang B; Jiang S; Cheng S
Biomed Pharmacother; 2017 Dec; 96():148-152. PubMed ID: 28972887
[TBL] [Abstract][Full Text] [Related]
13. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.
Wang C; Li Q; Li T
Exp Lung Res; 2020; 46(1-2):11-22. PubMed ID: 31931639
[No Abstract] [Full Text] [Related]
14. [Mechanism of lung and intestine combination therapy in treatment of acute lung injury by inhibiting inflammatory response based on NF-κB/NLRP3 signaling pathway and alveolar macrophage activation].
Kou YL; Wang WB; Yan SG; Li JT; Shi J; Hui Y
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):151-158. PubMed ID: 35178922
[TBL] [Abstract][Full Text] [Related]
15. Cardamine komarovii flower extract reduces lipopolysaccharide-induced acute lung injury by inhibiting MyD88/TRIF signaling pathways.
Chen Q; Zhang KX; Li TY; Piao XM; Lian ML; An RB; Jiang J
Chin J Nat Med; 2019 Jun; 17(6):461-468. PubMed ID: 31262458
[TBL] [Abstract][Full Text] [Related]
16. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo.
Chu X; Ci X; Wei M; Yang X; Cao Q; Guan M; Li H; Deng Y; Feng H; Deng X
J Agric Food Chem; 2012 Apr; 60(15):3947-54. PubMed ID: 22400806
[TBL] [Abstract][Full Text] [Related]
17. Sodium Butyrate Inhibits the Inflammation of Lipopolysaccharide-Induced Acute Lung Injury in Mice by Regulating the Toll-Like Receptor 4/Nuclear Factor κB Signaling Pathway.
Liu J; Chang G; Huang J; Wang Y; Ma N; Roy AC; Shen X
J Agric Food Chem; 2019 Feb; 67(6):1674-1682. PubMed ID: 30661349
[TBL] [Abstract][Full Text] [Related]
18. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
[TBL] [Abstract][Full Text] [Related]
19. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
20. Sevoflurane inhibits nuclear factor-κB activation in lipopolysaccharide-induced acute inflammatory lung injury via toll-like receptor 4 signaling.
Sun XJ; Li XQ; Wang XL; Tan WF; Wang JK
PLoS One; 2015; 10(4):e0122752. PubMed ID: 25875290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
